Saturday, 10 October 2026European Markets

AUGROS COSMETICS Stock Bullish Momentum With A 16.8% Jump On Thursday

Loading stream...

(vianews) - the market ended the session with augros cosmetics (augr.pa) jumping 16.8% to €5.70 on thursday while cac 40 rose 2.29% to €7,615.41.

about augros cosmetics

augros cosmetic packaging sa provides customized packaging solutions in france. the company offers decoration solutions for glass, plastic, and aluminum packaging materials. it serves the perfume, cosmetic, and spirit industries. the company is based in alençon, france. augros cosmetic packaging sa operates as a subsidiary of famille bourgine.

earnings per share

as for profitability, augros cosmetics has a trailing twelve months eps of €-0.54.

volatility

augros cosmetics's last week, last month's, and last quarter's current intraday variation average was a negative 0.41%, a negative 5.85%, and a positive 10.75%.

augros cosmetics's highest amplitude of average volatility was 0.41% (last week), 11.59% (last month), and 10.75% (last quarter).

volume

today's last reported volume for augros cosmetics is 1 which is 96.15% below its average volume of 26.

more news about augros cosmetics (augr.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com